Triapriglim 1mg/500mg/15mg Tablet ER
Marketer
Aprica Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Triapriglim 1mg/500mg/15mg Tablet ER
Glycemic control in adult type 2 diabetics is aided by the extended-release combination medication, Triapriglim 1mg/500mg/15mg Tablet ER. This medication, used alongside diet and exercise, enhances insulin effectiveness, thereby reducing blood glucose. Dosage and duration should strictly follow your physician's instructions; ingest it with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; in such cases, omit the missed dose. Never double the dose to compensate. Excessive intake risks hypoglycemia (low blood sugar). Concomitant use with other antidiabetic agents, alcohol, or meal skipping may precipitate hypoglycemia; regular blood glucose monitoring is crucial. Nausea, diarrhea, abdominal pain, headache, fractures, and respiratory infections are potential side effects. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function tests will be conducted prior to prescription. Limit alcohol consumption due to increased side effect risk.
Primary Ingredients of Triapriglim 1mg/500mg/15mg Tablet ER
No text provided. Please provide the text you want me to rephrase.
Uses of Triapriglim 1mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Triapriglim 1mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Triapriglim 1mg/500mg/15mg Extended-Release tablet should be swallowed whole with food; do not break, crush, or chew it.
Common Side effects of Triapriglim 1mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triapriglim 1mg/500mg/15mg Tablet ER:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume the Triapriglim 1mg/500mg/15mg Extended-Release tablet with food.
How Triapriglim 1mg/500mg/15mg Tablet ER works:
Triapriglim ER tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triapriglim 1mg/500mg/15mg ER tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Triapriglim tablets (1mg/500mg/15mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Triapriglim tablets (1mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Triapriglim 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician. Triapriglim 1mg/500mg/15mg Extended-Release tablets are contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Triapriglim 1mg/500mg/15mg Extended-Release tablets cautiously, as dose modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication; physician consultation is advised.
What if you forget to take Triapriglim 1mg/500mg/15mg Tablet ER :
Should you forget to take your Triapriglim 1mg/500mg/15mg Extended-Release Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Triapriglim 1mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
3,018 People bought this recently